Efficacy and safety of different doses of alirocumab in reducing low-density lipoprotein cholesterol levels: a network meta-analysis | |
Pan, Ruirong[1]; Li, Yanyan[2]; Zhou, Hongwen[3] | |
刊名 | PHARMAZIE
![]() |
2019 | |
卷号 | 74期号:1页码:8-14 |
ISSN号 | 0031-7144 |
DOI | http://dx.doi.org/10.1691/ph.2019.8584 |
URL标识 | 查看原文 |
收录类别 | SCI(E) |
WOS记录号 | WOS:000457687700002 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5324279 |
专题 | 江苏大学 |
作者单位 | 1.[1]Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Affiliated Hosp, Dept Endocrinol & Metab, Zhenjiang, Peoples R China. 3.[3]Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China. |
推荐引用方式 GB/T 7714 | Pan, Ruirong[1],Li, Yanyan[2],Zhou, Hongwen[3]. Efficacy and safety of different doses of alirocumab in reducing low-density lipoprotein cholesterol levels: a network meta-analysis[J]. PHARMAZIE,2019,74(1):8-14. |
APA | Pan, Ruirong[1],Li, Yanyan[2],&Zhou, Hongwen[3].(2019).Efficacy and safety of different doses of alirocumab in reducing low-density lipoprotein cholesterol levels: a network meta-analysis.PHARMAZIE,74(1),8-14. |
MLA | Pan, Ruirong[1],et al."Efficacy and safety of different doses of alirocumab in reducing low-density lipoprotein cholesterol levels: a network meta-analysis".PHARMAZIE 74.1(2019):8-14. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论